Literature DB >> 17082777

Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2.

S Mishra, V Pertz, B Zhang, P Kaur, H Shimada, J Groffen, Z Kazimierczuk, L A Pinna, N Heisterkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17082777     DOI： 10.1038/sj.leu.2404460

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  30 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

Review 2.  NF-kappaB in carcinoma therapy and prevention.

Authors:  Matthew Brown; Jonah Cohen; Pattatheyil Arun; Zhong Chen; Carter Van Waes
Journal:  Expert Opin Ther Targets       Date:  2008-09       Impact factor: 6.902

3.  Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives.

Authors:  Christian Borgo; Luca Cesaro; Valentina Salizzato; Maria Ruzzene; Maria Lina Massimino; Lorenzo A Pinna; Arianna Donella-Deana
Journal:  Mol Oncol       Date:  2013-08-22       Impact factor: 6.603

Review 4.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

Review 5.  Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.

Authors:  Chandrika Gowda; Mario Soliman; Malika Kapadia; Yali Ding; Kimberly Payne; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2017-06-13

6.  In vitro effect of curcumin in combination with chemotherapy drugs in Ph+ acute lymphoblastic leukemia cells.

Authors:  Uriel Francisco Santana-Bejarano; Lucina Bobadilla-Morales; Lucero Mendoza-Maldonado; Elizabeth Torres-Anguiano; Sinhue Alejandro Brukman-Jiménez; Cesar Cenobio Barba-Barba; Jorge Román Corona-Rivera; Alfredo Corona-Rivera
Journal:  Oncol Lett       Date:  2019-04-02       Impact factor: 2.967

7.  Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Authors:  Uri Rozovski; David M Harris; Ping Li; Zhiming Liu; Preetesh Jain; Ivo Veletic; Alessandra Ferrajoli; Jan Burger; Susan O'Brien; Prithviraj Bose; Philip Thompson; Nitin Jain; William Wierda; Michael J Keating; Zeev Estrov
Journal:  Mol Cancer Res       Date:  2017-01-27       Impact factor: 5.852

Review 8.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

Review 9.  A structural insight into CK2 inhibition.

Authors:  Marco Mazzorana; Lorenzo A Pinna; Roberto Battistutta
Journal:  Mol Cell Biochem       Date:  2008-07-15       Impact factor: 3.396

10.  Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites.

Authors:  A A Kramerov; M Saghizadeh; S Caballero; L C Shaw; S Li Calzi; M Bretner; M Montenarh; L A Pinna; M B Grant; A V Ljubimov
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.